Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Change in Cash (2022 - 2024)

Adial Pharmaceuticals' Change in Cash history spans 3 years, with the latest figure at -$1.5 million for Q4 2024.

  • For Q4 2024, Change in Cash fell 157.89% year-over-year to -$1.5 million; the TTM value through Dec 2024 reached $923443.0, up 178.61%, while the annual FY2025 figure was $2.1 million, 130.73% up from the prior year.
  • Change in Cash for Q4 2024 was -$1.5 million at Adial Pharmaceuticals, down from $1.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $6.6 million in Q1 2022 and bottomed at -$3.5 million in Q2 2022.
  • The 3-year median for Change in Cash is -$1.3 million (2023), against an average of -$192637.3.
  • The largest YoY upside for Change in Cash was 312.37% in 2024 against a maximum downside of 157.89% in 2024.
  • A 3-year view of Change in Cash shows it stood at -$1.8 million in 2022, then soared by 243.43% to $2.5 million in 2023, then tumbled by 157.89% to -$1.5 million in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Change in Cash are -$1.5 million (Q4 2024), $1.9 million (Q3 2024), and -$1.7 million (Q2 2024).